Hi
Would appear they have the Assay problem sorted.
Kurtzberg is still a believer.
Aloha.
- Forums
- ASX - By Stock
- MSB
- Ann: Remestemcel Clinical and Potency Studies Presented at Tandem
MSB
mesoblast limited
Add to My Watchlist
30.2%
!
$2.33

Ann: Remestemcel Clinical and Potency Studies Presented at Tandem, page-7
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.33 |
Change
0.540(30.2%) |
Mkt cap ! $2.995B |
Open | High | Low | Value | Volume |
$1.90 | $2.40 | $1.90 | $33.13M | 15.08M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
25 | 39913 | $2.33 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.34 | 103423 | 12 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
22 | 46476 | 2.330 |
17 | 72375 | 2.320 |
18 | 157965 | 2.310 |
17 | 345969 | 2.300 |
7 | 83983 | 2.290 |
Price($) | Vol. | No. |
---|---|---|
2.340 | 104698 | 11 |
2.350 | 183610 | 27 |
2.360 | 163897 | 28 |
2.370 | 146493 | 14 |
2.380 | 381380 | 22 |
Last trade - 12.31pm 18/07/2025 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |